Terumo Corp. (TRUMY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH) Proposed acquisition would add NeoCast™, an ...

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., which is developing NeoCast, a next-gene ...

Terumo BCT and CSL Plasma have mutually agreed to terminate their existing supply agreement following a mutually agreed transition period. The transition of the affected centers will proceed in ...

TOKYO -- Terumo and U.S.-based customer CSL Plasma have ended a supply agreement, the Japanese medical device manufacturer ...

UBS maintained its Buy rating and JPY 3,400.00 price target for Terumo on October 14, 2026, putting the target 47.67 percent ...

Terumo stock (ISIN JP3546800008) was last at JPY 2,324.5 on the Tokyo Stock Exchange on October 7, 2026, down 0.39 percent ...

Medical device giant Terumo (4543, TSE Prime) has announced an expected loss of approximately 97.5 billion yen due to the ...

Find insight on GSK, Terumo and more in the latest Market Talks covering the health care sector.

In March 2026, Terumo Corporation filed a shelf registration for up to ¥200 billion in bonds and, a few days earlier, Tata Elxsi announced the opening of the Terumo–Tata Elxsi Offshore Development ...

Terumo's Spectra Optia® Apheresis System Terumo's Spectra Optia® Apheresis System LAKEWOOD, Colo., U.S., and SANTA ROSA, Calif., U.S., July 27, 2022 (GLOBE NEWSWIRE) -- Acute kidney injury (AKI) and ...

Terumo is set to benefit from a resumption of elective medical procedures in developed markets, but also new product introductions in cardiology, neurology, and diabetes. Winning CSL's plasma ...